I have been pretty consistent with my views.
Firstly A2 is sitting on a pile of cash. I would like their attention fully focussed on how to make best use of this capital. Either invest in productive companies; do a share buy back or give the money to the owners of A2 via a dividend.
Secondly they have major publicly notified problems with their supply chain and demand in their largest market - China. I would like their attention fully focussed on resolving this issue to the benefit of shareholders.
Thirdly, There is a lot of reliance on China as a market. I would like them to fully focus on entry into IF accessible markets. I don't consider USA to be an assessable IF market
Fourtly I would like them to actually fully focus on turning a profit on their USA current operations.
Fifthly, I would like them to fully focus on alternative dairy based nutritional products they can market that will create a positive revenue to the business
Sixthly I would like to see a plannened ,and well managed and executed entry into the USA IF market if indeed that is a reasonable use of capital and resources.
- Forums
- ASX - By Stock
- A2M
- A2M Confirms its also submitted applications for FDA sales approvals in USA
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

A2M Confirms its also submitted applications for FDA sales approvals in USA, page-86
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online